Microneedle injection and infusion apparatus and method of using same

Inventors

Burton, Scott A. • Ng, Chin-Yee • Frits, Michael J. • Mathias, Richard R.

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Assignees

Kindeva Drug Delivery LP

Member
Kindeva Drug Delivery
Kindeva Drug Delivery

Kindeva Drug Delivery is a contract development and manufacturing organization specializing in advanced drug delivery systems including pulmonary, nasal, injectable, transdermal, and intradermal therapies. Services range from formulation and analytical development to commercial-scale, Annex 1-compliant GMP manufacturing across global facilities. The company brings integrated expertise in regulatory strategy, device engineering, process and technology transfer, and quality assurance, with a focus on sustainable solutions such as low-GWP propellants and microneedle patch platforms. Kindeva supports complex, patient-centric, and environmentally optimized therapies from product conception through commercialization.

Publication Number

US-11771878-B2

Patent

Publication Date

2023-10-03

Expiration Date


Abstract

A microneedle injection and infusion apparatus, and a method of using same. The apparatus can include a housing, a microneedle array holder for holding a microneedle array, and a shuttle that holds a cartridge (e.g., that contains an active agent). The microneedle array holder can be movable between a retracted position and an extended position. The shuttle can be movable between a first position in which the cartridge is not in fluid communication with a fluid path and a second position in which the cartridge is in fluid communication with the fluid path. The apparatus can further include an actuator movable between a first position and a second position. The method can include moving the actuator to its second position to allow the shuttle to move toward its second position, wherein movement of the shuttle toward its second position allows the microneedle array holder to move to its extended position.

Core Innovation

The invention relates to a method of using a microneedle injection apparatus for transdermal delivery in which a microneedle array holder moves between a retracted position and an extended position relative to an opening in a base of a housing. In the retracted position, the microneedle array is recessed within the housing such that the microneedle array does not contact the skin surface when the apparatus is positioned on the skin surface. In the extended position, at least a portion of the microneedle array is positioned to contact the skin surface via the opening when the apparatus is positioned on the skin surface.

The microneedle injection apparatus includes a shuttle configured to hold and carry a cartridge, where the cartridge defines a reservoir configured to contain an active agent. The shuttle is movable between a first position in which the reservoir is not in fluid communication with a fluid path and a second position in which the reservoir is in fluid communication with the fluid path. The actuator is movable between a first position and a second position, and moving the actuator to the second position allows the shuttle to move toward the second position, thereby permitting fluid communication to be established with the fluid path.

Moving the actuator to the second position allows the microneedle array holder to move to the extended position, so that the shuttle movement and the microneedle array holder movement are coordinated as part of the method. The document further describes hollow microneedles defining a lumen and a fluid path configured to pass through the microneedles, with a piston/plunger that forces an active agent from the reservoir into the fluid path. Additional mechanics described include timing/latching and stop features to control shuttle movement, along with sterility features including a piercing element with a deformable sterility seal and an infusion progress indicator visible through a window.

Claims Coverage

The provided independent claims are 1 and 19. Across these claims, three core inventive features are described: actuator-permitted shuttle movement to establish fluid communication, coordinated movement of a microneedle array holder from retracted to extended skin contact, and stop-based release with stored energy driving of shuttle motion.

Actuator-permitted shuttle movement for reservoir-to-fluid-path communication

An actuator is movable between a first position and a second position, and moving the actuator to the second position allows the shuttle to move toward the second position, wherein movement of the shuttle toward the second position allows the cartridge reservoir to move from not in fluid communication with the fluid path to being in fluid communication with the fluid path.

Coordinated microneedle array holder transition from retracted to extended skin contact

A microneedle array holder holds a microneedle array and is movable between a retracted position in which the microneedle array is recessed within the housing such that the microneedle array does not contact the skin surface when the apparatus is positioned on the skin surface, and an extended position in which at least a portion of the microneedle array is positioned to contact the skin surface via the opening in the base when the apparatus is positioned on the skin surface.

Actuator releasing shuttle stop and stored energy device drive

The actuator includes a shuttle stop movable between a first position that engages at least a portion of the shuttle to hold the shuttle in the first position and a second position in which the shuttle stop no longer engages the shuttle to hold the shuttle in the first position, and a stored energy device is configured to drive the shuttle toward the second position.

The independent claims cover methods that coordinate actuator movement with shuttle movement to establish reservoir-to-fluid-path fluid communication, and coordinate the microneedle array holder transition from a retracted, skin-noncontact position to an extended, skin-contact position via the opening. The claim set also includes stop-based release and stored energy driving of shuttle motion.

Stated Advantages

Not explicitly described in patent.

Documented Applications

Not explicitly described in patent.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.